Veloxis aims to be as responsive to media inquiries as possible. If you require further information, would like an interview with Veloxis management, or would like to be added to our media distribution list, please contact:
Brett Fleshman, VP, Strategy & Corporate Development
Veloxis Pharmaceuticals Inc.
Nov 15, 2017
Q3 Report 2017 Investor Call